- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03381339
Powertoothbrushing for Treating Gingivitis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53233
- Marquette University School of Dentistry
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
A subject who meets all the following criteria will be eligible to enroll in this study.
- Age range 18 - 65 years
- Routine manual toothbrush user
- A Subject who agrees to use the assigned toothbrush as the only cleaning device for the study duration, refraining from daily interdental cleaning and/ or antiseptic mouthrinsing.
- Mild to moderate gingivitis as measured by A. Modified Gingival Index (MGI) average score of at least 1.2, and / or B. Bleeding on Probing (BOP) of at least 20% of all sites but not more than 50% of sites.
- Probing Pocket Depth (PPD) of 4 mm or lower
- At least 20 natural teeth - scoreable (crowns or bridgework are non-scoreable).
Exclusion Criteria:
Any subject meeting one of the following criteria will not be included in the study.
- Daily user of interdental cleaning devices, such as floss, floss picks, toothpicks, interdental brush, water flossing device
- Regular user of antimicrobial mouthrinses within one week of entry into study
- Professional prophylaxis within one month of entry into the study
- Use of antibiotics within one month prior to the baseline exam
- Signs of moderate to severe periodontitis or caries, categorized as PPD of 5 mm of higher and attachment loss of 3 mm or higher
- Subjects with orthodontic bands and/or dental appliances.
- Participated in an oral care related study in the last 90 days prior to this study
- Pregnant or lactating women
- Patients with a history of significant cardiovascular disease, diabetes, cancer, AIDS, or other organ impairment that would preclude their participation in the study
- Acute/concurrent illness such as hepatitis, herpes simplex infections, influenza, etc.
- History of rheumatic fever, cardiovascular valvular disease, artificial joint replacement or kidney or liver disorders
- Chronic use of steroids; limited use of NSAID's (≤ 325 mg/day)
- Current Smoker (within the last 3 months)
- Other medical or dental conditions that would affect the study
- Inability to commit to all necessary study visits from baseline to 12 weeks
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Powered toothbrush intervention
Subjects will be provided an oscillating rotating powered toothbrush as the experimental intervention, and given written instructions on its proper use.
Efficacy of overnight plaque reduction will be assessed at baseline and both gingivitis and plaque reduction will be assessed as change from baseline at 2, 4 and 12 weeks.
Subjects will be given a standard fluoride toothpaste and asked to refrain from daily interproximal plaque control for the duration of the study.
|
a battery powered oscillating rotating toothbrush will be used for twice daily regular home dental hygiene
Other Names:
|
No Intervention: Manual toothbrush
Subjects will be provided a manual toothbrush as the control group and given written instructions on its proper use.
Efficacy of overnight plaque reduction will be assessed at baseline and both gingivitis and plaque reduction will be assessed as change from baseline at 2, 4 and 12 weeks.
Subjects will be given a standard fluoride toothpaste and asked to refrain from daily interproximal plaque control for the duration of the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Gingivitis
Time Frame: 12 weeks post-baseline
|
Baseline and 12 weeks post-baseline measures. Proportion of bleeding sites per patient was used as Full mouth BOP Score. The score for each site was either 1 for bleeding and 0 for no bleeding. Following is the full description of each outcome measure reported in the protocol. The Modified Gingival Index3 (MGI) will be measured on six sites - mesio-buccal, buccal, disto-buccal, mesio-lingual, lingual and disto-lingual - of all teeth using a 0-4 scale. Lower score no inflamation and higher severe inflammation. Dental plaque will be evaluated using the Lobene modification4 of the Turesky modification of the Quigley-Hein Plaque Index (PI)5. The score 0 to 5. Lower score means no plaque and higher score increasing plaque.Full-mouth Probing Pocket Depth (PPD) will be measured on the six locations of each tooth (mesial-buccal, buccal, distal-buccal, mesial-lingual, lingual, distal-lingual) using a periodontal probe. |
12 weeks post-baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MarquetteU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gingivitis
-
Zainab J AbbasCompleted
-
University of SaskatchewanCompletedChronic Gingivitis | Chronic Gingivitis, Plaque InducedCanada
-
Tufts UniversityGuangdong Bixdo Health Technology Co., Ltd.Not yet recruitingPlaque Induced GingivitisUnited States
-
Cairo UniversityNot yet recruiting
-
Hospital Universiti Sains MalaysiaRecruitingGingivitis | Plaque Induced GingivitisMalaysia
-
Lander Enterprises, LLCCompletedPlaque Induced GingivitisUnited States
-
University of WashingtonColgate PalmoliveCompleted
-
Tokat Gaziosmanpasa UniversityAbant Izzet Baysal UniversityCompletedPregnancy Gingivitis
-
Maharishi Markendeswar University (Deemed to be...CompletedChronic GingivitisIndia
-
Ain Shams UniversityCompleted
Clinical Trials on Oscillating rotating power toothbrush
-
University of ManitobaCanadian Foundation for Dental Hygiene Research and EducationCompletedPeriodontal DiseaseCanada
-
Procter and GambleCompletedGingivitis | Dental PlaqueUnited States
-
Procter and GambleCompletedGingivitis | PlaqueUnited States
-
University of MilanCompletedGingival RecessionItaly
-
Riccardo PolosaRecruitingDental Plaque | Calculus, DentalItaly
-
Procter and GambleCompletedGingivitis | Dental PlaqueCanada
-
Philips Clinical & Medical Affairs GlobalCompleted
-
University Hospital Schleswig-HolsteinProcter and GambleCompletedGingival Recession
-
Lander Enterprises, LLCCompletedPlaque Induced GingivitisUnited States
-
Johnson & Johnson Consumer and Personal Products...CompletedDental Devices, Home CareUnited States